Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GE invests in cardiovascular IVD with CardioDx alliance

This article was originally published in Clinica

Executive Summary

GE Healthcare has invested $5m CardioDx, a privately-held company specialising in cardiovascular genomic diagnostics. The move is consistent with the company's strategy to expand out of in vivo and into in vitro diagnostics. The news, announced today, also marks the first investment for GE's $250m Healthymagination fund, which was launched last year as part of a $6bn initiative to improve and increase healthcare access.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT094689

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel